Imugene presents positive new data at key congress | News Direct

Imugene presents positive new data at key congress

Imugene Ltd
Digital Asset Direct by Imugene Ltd
Download PDF Download multimedia

facebook icon linkedin icon twitter icon pinterest icon email icon Melbourne, Victoria | December 06, 2022 01:30 PM Eastern Standard Time

Imugene Ltd (ASX:IMU) CEO Leslie Chong speaks with Proactive soon after positive new data regarding overall survival results in its HER-Vaxx HERIZON study was provided in an oral presentation at the ESMO Asia Congress 2022 in Singapore. Chong also discusses upcoming conferences and investor presentations including the JP Morgan Healthcare Conference 2023 in January in which Imugene has been invited to attend and speak.

 

Contact Details

 

Proactive Investors

 

Jonathan Jackson

 

+61 413 713 744

 

Jonathan@proactiveinvestors.com

DOWNLOAD

project media

Tags

Imugene LtdhealthAsxproactiveAustraliaproactiveInvestors
News Direct Logo
Follow us on Facebook Follow us on LinkedIn
Get the latest from News Direct
Contact Us Pricing
Why News Direct
About us Features News Hub
Resources
Terms of Use Privacy Policy
newsdirect.com © 2024 News Direct Corp. All rights reserved. News Direct is a registered trademark.